Boyu Capital
PE-backed CStone files for Hong Kong IPO
CStone Pharmaceuticals, a cancer-focused Chinese biopharmaceutical developer with a number of PE and VC backers, has filed for an IPO in Hong Kong.
PE-backed WuXi AppTec targets Hong Kong listing
Wuxi AppTec, a contract pharmaceutical R&D services provider backed by several private equity investors, has filed for a Hong Kong listing less than four months after listing in Shanghai. The size and pricing of the IPO have yet to be decided, but the...
China's Lianlian Payment raises $146m from Sequoia, Boyu
China’s Lianlian Digital, the parent company of payment services provider Lianlian Pay, has raised RMB1 billion ($146 million) from Sequoia Capital China and Boyu Capital in its latest funding round.
Hong Kong's Klook gets $200m Series D
Hong Kong travel services company Klook has closed a $200 million Series D funding round from a group of investors including Sequoia Capital China, Matrix Partners, and Goldman Sachs.
Boyu leads $125m round for Singapore's Trax
Boyu Capital has led a $125 million funding round for Trax, a Singapore-headquartered company that has developed computer vision and analytics solutions through which retailers can link sales to in-store and on-shelf positioning.
Brii Biosciences gets $260m for China expansion
A group of VCs, including Sequoia Capital, have committed $260 million to Brii Biosciences, a China and US-based healthcare start-up executing a number of China-focused growth initiatives.
GIC leads $260m round for China's CStone Pharma
Singapore’s GIC Private has led a $260 million Series B investment in China’s CStone Pharmaceuticals. The round, completed within two months, is said to be the largest biopharma Series B in the country to date.
Chinese GPs back AstraZeneca spin-out
A consortium led by Boyu Capital, 6 Dimensions Capital and Hillhouse Capital will invest up to $250 million in Viela Bio, a pharmaceutical research and development company being spun out from AstraZeneca.
China's Easyhome raises $2b from Alibaba, PE investors
Alibaba Group has joined a group of PE investors to acquire a 36% interest in Beijing Easyhome Furnishing, China’s second-largest home improvement supplies and furniture chain operator, in a deal worth RMB13 billion ($2 billion).
PE-backed WuXi Biologics completes Hong Kong re-listing
WuXi Biologics, a Chinese contract R&D services provider to the global pharmaceutical industry that was taken private by a PE-backed consortium in late 2015, gained 38% on its Hong Kong trading debut following a HK$3.97 billion ($510 million) IPO.
Boyu acquires 25% of China Vanke's property services unit
Boyu Capital has bought a 25% stake in Vanke Property Development, a wholly-owned property services unit of China Vanke, the second-largest real estate developer in the country, for RMB166 million ($24 million).
PE investors join $1.53b financing round for Baidu's iQiyi
China’s iQiyi.com, a video-streaming platform majority-owned by search giant Baidu, has raised $1.53 billion from a group of private equity investors through the sale of convertible notes.
PE-backed New Century Healthcare targets $129m HK IPO
New Century Healthcare, a Chinese pediatric hospital operator backed by CDH Investments and Boyu Capital, is planning to raise HK$1 billion ($129 million) via a Hong Kong IPO.
COFCO Meat completes $252m Hong Kong IPO
COFCO Meat, a subsidiary of Chinese agricultural conglomerate COFCO Group that received backing from four private equity firms in 2014, has raised HK$1.95 billion ($252 million) in its Hong Kong IPO, after pricing the offering at bottom of the indicative...
WuXi, Boyu, Oriza commit $150m to China's CStone
WuXi Healthcare Ventures, Oriza Seed Venture Capital, and Boyu Capital have committed $150 million in Series A funding to Chinese bio-pharmaceutical developer CStone Pharmaceuticals.
Telstra completes sale of Autohome stake to Ping An
Australia’s Telstra has closed the sale of a 47.7% interest in Chinese auto services company Autohome to Ping An Insurance Group for $1.6 billion.
Autohome shareholders challenge sale to China's Ping An
Minority shareholders of Chinese auto services company Autohome have filed a petition against a recent move by Telstra to sell the majority of its controlling stake to Ping An Insurance Group for $1.6 billion.
PE consortium battles Ping An for China's Autohome
Boyu Capital, Hillhouse Capital and Sequoia Capital have submitted a take-private offer for Chinese auto listings and information service Autohome. This follows Telstra agreeing to sell its majority stake in the business to Ping An Insurance Group.
PE consortium completes take-private of China's WuXi PharmaTech
A consortium comprising the founder and CEO of WuXi PharmaTech and several PE investors has completed the privatization of the China-based provider of contract R&D services to global pharmaceutical companies.
WuXi Pharmatech wins endorsement for PE-backed take-private
The proposed privatization of WuXi PharmaTech, a China-based provider of contract R&D services to the global pharmaceutical sector, has won the support of two major shareholder proxy advisory firms.
Boyu joins Chinese consortium for $2.5b GLP investment
Boyu Capital and several Chinese strategic investors have joined a consortium that has committed $2.5 billion to Global Logistic Properties (GLP), a Singapore-listed warehouse operator.
PE consortium to build hog farms with China's COFCO Meat
KKR, Baring Private Equity Asia, Hopu Investments and Boyu Capital will invest in COFCO Meat, a subsidiary of Chinese agricultural conglomerate COFCO Group, to develop hog farms and meat processing plants.
China's Ctrip invests $200m in VC-backed Tongcheng
Tongcheng Network Technology, the VC-backed business behind travel site 17u.com and ticketing site LY.com, has received $200 million Ctrip International.
China travel site 17u raises $82m from Tencent, Boyu, Oriza
Chinese online travel agency 17u.cn has received a RMB500 million ($82 million) round of investment from Tencent Holdings, Boyu Capital and Oriza Holdings.